-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Sumitomo Pharma Co Ltd - Sumitomo Pharma America Announces Enzomenib (Dsp-5336) Receives FDA Breakthrough Therapy Designation For Treatment Of R/R Kmt2a-Rearranged Acute Leuke

Reuters·10/27/2026 00:08:58

Please log in to view news